Back

GENERAL TERMS OF USE

Although you are free to browse, in whole or in part, this website (the "Site"), you are informed and agree that your access to and use of the Site are subject to compliance with these general terms of use and applicable laws. The Site is intended for use by individuals residing in France. Any use of the content or any link to the content of the Site other than under the conditions defined below is strictly prohibited.

1. LEGAL NOTICE

This Site is published by PFIZER, a simplified joint-stock company with a capital of 47,570 euros, registered with the Paris Trade and Companies Register under number B 433 623 550, with its registered office located at 23-25, avenue du Docteur Lannelongue 75014 Paris ("Pfizer"), tenant-manager of PFIZER Holding France. Telephone: 0158073000. The publication director is Mr. David Lepoittevin, director of the vaccines unit of Pfizer France. The hosting provider is Acquia, 53 State Street 10th Floor, Boston, MA 02109 USA, registered under the number 26-0493001. Telephone: +1 888-922-7842. The Site is hosted in the European Economic Area.

2. LIMITATION OF LIABILITY

2.1 Nature and scope of information provided on the Site

The purpose of the Site is to provide information or services related to the activities of Pfizer, a company operating in the pharmaceutical field. It includes general information intended for the public and is intended for use by individuals residing in France. The user acknowledges being fully informed that the information contained on the Site is not intended in any way to:

The user is informed that a doctor or any other competent healthcare professional should be consulted before using any product or before using any information on the Site.

2.2 Site Content

The Site includes content from several entities of the Pfizer Group in France. The Site may also reproduce opinions expressed by experts that may be of interest to users. These pieces of information should only be considered as the opinions of the experts from whom they originate.

2.3 Site Updates

Pfizer makes its best efforts to provide up-to-date information on the Site. However, the information provided may require an update that may not have occurred at the time of user consultation. Pfizer cannot be held responsible for any errors or omissions.

2.4 Viruses

It is expressly reminded that the Internet is not a secure network. The user of the Site acknowledges that the use of their technical equipment remains entirely their responsibility. It is therefore up to users to take all appropriate measures to protect their equipment and the data stored on their equipment against any harm, including but not limited to any form of contamination by viruses and/or intrusion attempts, and to back up their data. Pfizer declines all responsibility in the event of damages suffered by the user which are not attributable to Pfizer, due in particular to the loss, deterioration, or alteration of files, the transmission of viruses that could infect their computer equipment or any other property during the connection and/or consultation and/or use of the Site.

2.5 Hyperlinks

The Site may provide links to other sites whose content Pfizer does not control. Their access and use are solely and entirely the user's responsibility and subject to any terms of use that may apply on those third-party websites.

3. INTELLECTUAL PROPERTY

The Site, including all its elements taken separately, visuals, layout, texts, comments, still or animated images, sounds, graphics, content of all articles, press reviews, and more generally any information on the Site, is the exclusive property of Pfizer or third parties with whom Pfizer has entered into agreements allowing reproduction and distribution. Except for the user's personal use in accordance with applicable law, any reproduction, distribution, and more generally any exploitation in whole or in part of the Site is subject to prior, express and written authorization from Pfizer. Any use of data or information from the Site duly authorized by Pfizer must necessarily mention Pfizer or the person or entity who authored the information as the source of the information. The names and logos owned by Pfizer, including the names and logos that may be associated with the Site, are registered and protected trademarks and domain names protected by Pfizer. Any use of these names and/or logos requires prior express written permission from Pfizer. Any hyperlink from a third-party website allowing access to the Site or any of its pages requires prior written authorization from Pfizer. Pfizer declines all responsibility for the content of these third-party sites linked to the Site and concerning these links in general. Failure to obtain authorization from Pfizer to exploit or use the aforementioned elements or to establish a link to the Site may subject the user to civil and/or criminal proceedings.

4. PHARMACOVIGILANCE

Any adverse effect related to a Pfizer product must be reported immediately by email to [email protected].

5. PERSONAL DATA

In connection with the use of the Site, Pfizer may collect and process personal data concerning users under the conditions defined in our personal data protection policy accessible by clicking here and in our cookie policy accessible by clicking here.

6. APPLICABLE LAW

In connection with the use of the Site, Pfizer may collect and process personal data concerning users under the conditions defined in our personal data protection policy accessible by clicking here and in our cookie policy accessible by clicking here.

7. UPDATES

These general terms of use may be updated by Pfizer at any time and without notice. The updates to these terms will take effect upon their publication on the Site. We encourage you to regularly review these general terms of use of the Site.

References

Content updated on November 25, 2023 Copyright © 2020-2023 Pfizer Inc. All rights reserved.

The content of this site is intended for individuals residing in France. The information provided on this site serves as general information and is for educational purposes. It is not intended to replace advice provided by a doctor or other qualified healthcare professionals. Content provided by Pfizer, a simplified joint-stock company with a capital of 47,570 €. Registered Office 23-25 avenue du Docteur Lannelongue - 75014 Paris 433 623 550 RCS Paris. SIREN 433 623 550. SIRET 433 623 550 00020. Intra-Community Value Added Tax (VAT) number FR 73 433 623 550. Tenant-manager of Pfizer Holding France.

Style
No-navigation
id
No-navigation